Without prejudice to the generality of Article 9 and Article 10(1), implementing measures may be laid down, or amendments to Annex II or III adopted, in accordance with the procedure referred to in Article 12(2):
1)
to lay down rules for the transport of meat while it is warm;
2)
to specify, in respect of MSM, which calcium content is not significantly higher than that of minced meat;
3)
to lay down other treatments that may be applied in a processing establishment to live bivalve molluscs from class B or C production areas that have not been submitted to purification or relaying;
4)
to specify recognised testing methods for marine biotoxins;
5)
to lay down additional health standards for live bivalve molluscs in cooperation with the relevant Community Reference Laboratory, including:
(a)
limit values and analysis methods for other marine biotoxins;
(b)
virus testing procedures and virological standards; and
(c)
sampling plans and the methods and analytical tolerances to be applied to check compliance with the health standards;
6)
to lay down health standards or checks, where there is scientific evidence indicating that they are necessary to protect public health;
7)
to extend Annex III, Section VII, Chapter IX, to live bivalve molluscs other than pectinidae;
8)
to specify criteria for determining when epidemiological data indicate that a fishing ground does not present a health hazard with regard to the presence of parasites and, consequently, for determining when the competent authority may authorise food business operators not to freeze fishery products in accordance with Annex III, Section VIII, Chapter III, Part D;
9)
to lay down freshness criteria and limits with regard to histamine and total volatile nitrogen for fisheries products;
10)
to permit the use for the manufacture of certain dairy products of raw milk not meeting the criteria laid down in Annex III, Section IX, as regards its plate count and somatic cell count;
11)
without prejudice to Directive 96/23/EC (35), to fix a maximum permitted value for the combined total of residues of antibiotic substances in raw milk; and
12)
to approve equivalent processes for the production of gelatine or collagen.